Table 4. 2.
Chromosomal region | Status | Frequency | Relation with MYCN amplification | Involved genes | Clinical group |
---|---|---|---|---|---|
1p36 | Loss | 25–35% | Correlation | CHD5, miR-34a, KIF1Bβ | Unfavorable |
11q23 | Loss | 35–45% | Inversed correlation | TSLC1/IGSF4 | Unfavorable |
14q23 | Loss | 16–27% | Inversed correlation | All groups | |
17q22 | Gain | ~50% | Correlation | Survivin, NM23A | Unfavorable |